Article:
Biomarkers of Electroconvulsive Therapy (ECT) Response in Treatment-resistant Schizophrenia (TRS)

Research Projects

Organizational Units

Abstract
ABSTRACT Electroconvulsive therapy (ECT) is a well-established treatment option for individuals with treatment-resistant schizophrenia (TRS). However, predicting treatment response and identifying potential biomarkers to guide electroconvulsive therapy interventions in treatment-resistant schizophrenia remains a challenge. This review paper aims to explore the current literature on clinical biomarkers associated with electroconvulsive therapy in treatment-resistant schizophrenia. We discuss various potential biomarkers, including clinical, neuroimaging findings, EEG markers, and genetic markers, that have shown promise in predicting electroconvulsive therapy response and understanding the underlying mechanism of action. Additionally, we highlight the limitations and future directions for research in this field. KEY WORDS Biomarkers, Electroconvulsive therapy, Treatment-resistant schizophrenia
Description
Sharma P,1 Sharma P2 1Department of Psychiatry University of California Riverside, CA 92521 2Post Doc Researcher Yale University
Keywords
Biomarkers, Electroconvulsive therapy, Treatment-resistant schizophrenia

Identifier

Citation

Collections

Collections